Skip to ContentSkip to Navigation
About usNews and EventsNews articles

Trombotic complications in liver transplantation

07 September 2009

PhD ceremony: N. Warnaar, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen

Thesis: Trombotic complications in liver transplantation

Promotor(s): prof. R.J. Porte, prof. J.A. Lisman

Faculty: Medical Sciences

 

Orthotopic liver transplantation (OLT) is a successful treatment for patients with end-stage acute or chronic liver disease. Historically OLT was a major surgical procedure, often complicated by massive blood loss. The traditional concept on contributors to this bleeding included coagulation abnormalities secondary to the preexisting liver disease. Anti-hemostatic agents were thought to be contraindicated.

Recent studies though show that overall hemostatic function in patients with cirrhosis may not be as abnormal as traditionally believed. The alterations concern both pro- and anti-hemostatic pathways, resulting in a rebalanced system, albeit with more narrow margins. These patients are therefore not only at risk for bleeding, but also for thromboembolic complications.

Multiple cases of central venous thromboembolic events during or after OLT have been described. Also the development of hepatic artery thrombosis (HAT) is a dreaded complication. In this thesis the literature on this subject is reviewed and two studies are described regarding the incidence of and risk factors for the development of central venous thromboembolic events in OLT. Another study describes the long-term results of urgent intervention for HAT after pediatric OLT. The impact of intraoperative use of antifibrinolytic drugs in OLT on the development of thromboembolic complications and renal dysfunction was studied; and no association was found. In conclusion: a) patients with liver failure are not exempt from thromboembolic complications, which are not uncommon. b) the use of antifibrinolytic drugs in OLT is safe and does not increase the number of thromboembolic complications. c) anti-hemostatic drugs shouln’t be contraindicated in patients undergoing OLT and more research is warranted on this subject.

 

Last modified:15 September 2017 3.38 p.m.
printView this page in: Nederlands

More news

  • 15 October 2019

    Meiden die ‘aan de pil’ zijn hebben vaker depressieve gevoelens

    Zestienjarige meisjes die de anticonceptiepil gebruiken hebben vaker depressieve klachten dan leeftijdsgenoten die niet aan de pil zijn. Dat blijkt uit een studie van onderzoekers van het UMCG, LUMC en Brigham and Women’s Hospital. Ze publiceren hun...

  • 11 October 2019

    Down Under with Top Dutch

    After two years of hard work, the Groningen Top Dutch Solar Racing team has arrived in Australia. The team consists of students of the Hanze University of Applied Sciences, University of Groningen, and secondary vocational education (MBO) and is currently...

  • 08 October 2019

    Making a splash in whale research

    He disliked genetics as an undergraduate and never really wanted to work with whales. Yet, Per Palsbøll became a worldwide expert in the genetics of marine mammals, heading a research programme spanning the entire globe. Introducing the concept of...